|
1
|
Al-Ejeh F, Smart CE, Morrison BJ, et al:
Breast cancer stem cells: treatment resistance and therapeutic
opportunities. Carcinogenesis. 32:650–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: the 4 R’s of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morrison R, Schleicher SM, Sun Y, et al:
Targeting the mechanisms of resistance to chemotherapy and
radiotherapy with the cancer stem cell hypothesis. J Oncol.
2011:9418762011. View Article : Google Scholar
|
|
4
|
Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab
T and Lin J: STAT3 signaling pathway is necessary for cell survival
and tumorsphere forming capacity in
ALDH+/CD133+ stem cell-like human colon
cancer cells. Biochem Biophys Res Commun. 416:246–251. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chuthapisith S, Eremin J, El-Sheemey M and
Eremin O: Breast cancer chemoresistance: emerging importance of
cancer stem cells. Surg Oncol. 19:27–32. 2010. View Article : Google Scholar
|
|
6
|
Resetkova E, Reis-Filho JS, Jain RK, Mehta
R, Thorat MA, Nakshatri H and Badve S: Prognostic impact of ALDH1
in breast cancer:a story of stem cells and tumor microenvironment.
Breast Cancer Res Treat. 123:97–108. 2010. View Article : Google Scholar
|
|
7
|
Croker AK and Allan AL: Inhibition of
aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and
radiation resistance of stem-like ALDHhiCD44+
human breast cancer cells. Breast Cancer Res Treat. 133:75–87.
2012. View Article : Google Scholar
|
|
8
|
Wang Z, Li Y, Banerjee S, et al:
Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer
cell growth, migration and invasion and induces apoptosis via
inactivation of Akt, mTOR and NF-kappaB signaling pathways. J Cell
Biochem. 109:726–736. 2010.PubMed/NCBI
|
|
9
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
South AP, Cho RJ and Aster JC: The
double-edged sword of Notch signaling in cancer. Semin Cell Dev
Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
12
|
Kaler P, Augenlicht L and Klampfer L:
Activating mutations in β-catenin in colon cancer cells alter their
interaction with macrophages; the role of snail. PloS One.
7:e454622012. View Article : Google Scholar
|
|
13
|
Bruni-Cardoso A, Lynch CC, Rosa-Ribeiro R,
Matrisian LM and Carvalho HF: MMP-2 contributes to the development
of the mouse ventral prostate by impacting epithelial growth and
morphogenesis. Dev Dyn. 239:2386–2392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Piccart-Gebhart MJ, Procter M,
Leyland-Jones B, et al; Herceptin Adjuvant (HERA) Trial Study Team.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast
cancer. N Engl J Med. 353:1659–1672. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burcombe RJ, Makris A, Richman PI, et al:
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to
neoadjuvant anthracycline chemotherapy for operable breast cancer.
Br J Cancer. 92:147–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones RL, Salter J, A’Hern R, et al: The
prognostic significance of Ki67 before and after neoadjuvant
chemotherapy in breast cancer. Breast Cancer Res Treat. 116:53–68.
2009. View Article : Google Scholar
|
|
17
|
Wei W, Li P, Nie LP, Hu H, Han B and Yu
ZQ: Detection of CD44+CD24−/low cells in
breast cancer stem cells and clinical significance. Chin J Exp
Surg. 27:711–713. 2010.
|
|
18
|
Guo CF, Lin LF, Li P and Wei W: Change and
clinical significance of
ALDH1highCD44+CD24−/low cells
content in peripheral blood of patients with breast cancer.
Maternal Child Health Care China. 27:4121–4123. 2012.
|
|
19
|
Charafe-Jauffret E, Ginestier C, Iovino F,
et al: Breast cancer cell lines contain functional cancer stem
cells with metastatic capacity and a distinct molecular signature.
Cancer Res. 69:1302–1313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolff AC, Hammond MEH, Schwartz JN, et al;
American Society of Clinical Oncology/College of American
Pathologists. American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for human epidermal
growth factor receptor 2 testing in breast cancer. Arch Pathol Lab
Med. 131:18–43. 2007.PubMed/NCBI
|
|
21
|
Tanei T, Morimoto K, Shimazu K, et al:
Association of breast cancer stem cells identified by aldehyde
dehydrogenase 1 expression with resistance to sequential Paclitaxel
and epirubicin-based chemotherapy for breast cancers. Clin Cancer
Res. 15:4234–4241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rizzo P, Miao H, D’Souza G, et al:
Cross-talk between notch and the estrogen receptor in breast cancer
suggests novel therapeutic approaches. Cancer Res. 68:5226–5235.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zang S, Chen F, Dai J, et al:
RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition
and enhanced chemosensitivity inhuman breast cancer. Oncol Rep.
23:893–899. 2010.PubMed/NCBI
|
|
24
|
Allred DC, Harvey JM, Berardo M, et al:
Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
25
|
Keam B, Im SA, Lee KH, et al: Ki-67 can be
used for further classification of triple negative breast cancer
into two subtypes with different response and prognosis. Breast
Cancer Res. 13:R222011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto S, Ibusuki M, Yamamoto Y, et al:
Clinical relevance of Ki67 gene expression analysis using
formalin-fixed paraffin-embedded breast cancer specimens. Breast
Cancer. 20:262–270. 2013. View Article : Google Scholar
|
|
27
|
Yerushalmi R, Woods R, Ravdin PM, et al:
Ki67 in breast cancer prognostic and predictive potential. Lancet
Oncol. 11:174–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheang MCU, Chia SK, Voduc D, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
